Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Peter C. Bates"'
Autor:
Toshiaki Tanaka, Andrea F. Attanasio, Peter C Bates, Akira Teramoto, Kazuo Chihara, Ekaterina Koledova, Akira Shimatsu, Hitoshi Kohno, Yuzuru Kato
Publikováno v:
European Journal of Endocrinology. :343-350
OBJECTIVE: To evaluate the influence of factors intrinsic to the Japanese population on consequences of growth hormone deficiency (GHD) and effects of GH treatment in adult Japanese hypopituitary patients with GHD. STUDY DESIGN: A 24-week, randomised
Publikováno v:
Clinical Therapeutics. 26:805-818
Background: Type 2 diabetes mellitus is a condition characterized by impaired insulin secretion and resistance to insulin-mediated glucose uptake and utilization. A number of oral antidiabetic medication are available for its treatment, including met
Autor:
Smiljana Ristic, Peter C Bates
Publikováno v:
Diabetes Technology & Therapeutics. 5:57-66
The altered pharmacokinetics of new rapid-acting insulin analogs make them very effective in controlling blood glucose peaks after meals. However, simple replacement of regular human insulin by rapid-acting analogs may not be sufficiently effective f
Autor:
Pascale Mamessier, Gaetano Lombardi, Martin A. Birkett, Paul Frewer, Josef Marek, Peter H. Sönksen, Andrea F. Attanasio, Anne Kehely, Werner F. Blum, Peter C Bates, Ken K. Y. Ho, David Russell-Jones, Shereen Ezzat, Anton Luger
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:1974-1979
The aim of GH replacement therapy in GH-deficient adults is to optimize response with minimum incidence of adverse reactions, but optimal therapy regimens are still to be established. This two-arm parallel study examined effects of two GH dose algori
Autor:
Andrea F. Attanasio, Charmian A. Quigley, Simon J Howell, Werner F. Blum, Stephen M Shalet, Peter C Bates, Paul Frewer
Publikováno v:
Clinical Endocrinology. 56:503-507
OBJECTIVE Human GH treatment of patients with childhood-onset (CO) growth hormone deficiency (GHD) ceases when they reach final height; this provides an opportunity to retest GH status in all patients before determining whether GH therapy will be req
Autor:
Susan M. Webb, Domenico Valle, Christian J. Strasburger, Keith Selander, Ken K. Y. Ho, Richard J. Ross, Brenda J. Crowe, Steven W. J. Lamberts, Roger Bouillon, Andrea F. Attanasio, Peter C Bates
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:1600-1606
The Hypopituitary Control and Complications Study is an international surveillance study evaluating efficacy and safety of GH therapy of adult GH-deficient patients in clinical practice. The present report examined baseline data from 1,123 adult onse
Autor:
Martin A. Birkett, Susanna Equiluz-Bruck, Peter C Bates, Klaudia Sandholzer, Wolfgang Wein, Guntram Schernthaner
Publikováno v:
Diabetes Care. 21:570-573
OBJECTIVE For intensified insulin therapy of type 1 diabetes, bolus injection of regular human insulin 30–15 min before a meal is currently recommended. This randomized study is aimed to determine whether insulin lispro (LIS), a new insulin analog
Autor:
Jannik Hilsted, Peter C Bates, Christian J. Strasburger, A. Attanasio, Martin A. Birkett, N. K. Valk, Bengt-Åke Bengtsson, Steven W. J. Lamberts, Anna M.C. Matranga
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:82-88
The onset of adult GH deficiency may be during either adulthood (AO) or childhood (CO), but potential differences have not previously been examined. In this study the baseline and GH therapy (12.5 micrograms/kg per day) data from CO (n = 74; mean age
Autor:
Peter C Bates
Publikováno v:
Expert Opinion on Therapeutic Patents. 6:379-384
Anxiety disorders include generalised anxiety disorders, panic disorders and obsessive-compulsive disorders. Patients suffer chronic and persistent apprehension and tension not relating to any real danger and this causes physical symptoms which inter
Publikováno v:
Expert Opinion on Therapeutic Patents. 4:917-930